Karyopharm Therapeutics Inc. (KPTI) insider trading

Insider

Date

Role

Action

Shares

Price

Amount

Kristin Abate

16 Oct 2026

Chief Accounting Officer

Sell

4,788

$0.34

$1.65K

Kristin Abate

1 Oct 2026

Chief Accounting Officer

Sell

378

$1.19

$449.82

Kristin Abate

1 Sep 2026

Chief Accounting Officer

Sell

19

$2.02

$38.38

Stuart Poulton

28 Jul 2026

EVP, Chief Development Officer

Sell

189

$7.10

$1.34K

Michael Mano

14 May 2026

EVP, CLO&Secretary

Sell

266

$9.50

$2.53K

Richard A. Paulson

14 May 2026

President and CEO

Sell

2,203

$9.50

$20.93K

Kristin Abate

14 May 2026

Chief Accounting Officer

Sell

53

$9.50

$503.50

Sohanya Roshan Cheng

14 May 2026

EVP & Chief Commercial Officer

Sell

324

$9.50

$3.08K

Reshma Rangwala

14 May 2026

EVP & Chief Medical Officer

Sell

408

$9.50

$3.88K

Stuart Poulton

14 May 2026

EVP, Chief Development Officer

Sell

403

$9.50

$3.83K

Reshma Rangwala

21 Apr 2026

EVP & Chief Medical Officer

Sell

449

$8.94

$4.01K

Stuart Poulton

2 Mar 2026

EVP, Chief Development Officer

Sell

5,101

$9.41

$48.00K

Richard A. Paulson

2 Mar 2026

President and CEO

Sell

12,361

$9.41

$116.31K

Reshma Rangwala

2 Mar 2026

EVP & Chief Medical Officer

Sell

5,066

$9.41

$47.67K

Sohanya Roshan Cheng

2 Mar 2026

EVP & Chief Commercial Officer

Sell

4,604

$9.41

$43.32K

Michael Mano

2 Mar 2026

EVP, CLO&Secretary

Sell

3,526

$9.41

$33.18K

Kristin Abate

2 Mar 2026

Chief Accounting Officer

Sell

559

$9.41

$5.26K

Stuart Poulton

17 Feb 2026

EVP, Chief Development Officer

Sell

378

$8.63

$3.26K

Lori Macomber

3 Feb 2026

EVP, CFO & Treasurer

Sell

1,626

$6.30

$10.24K

Kristin Abate

28 Jan 2026

Chief Accounting Officer

Sell

50

$7.03

$351.50

Kristin Abate

21 Jan 2026

Chief Accounting Officer

Sell

265

$5.96

$1.58K

Karyopharm Therapeutics Inc.

What the insiders did Net selling

Individual transactions

What was left out